News

India Introduces New BPaLM Regimen to Combat Drug-Resistant Tuberculosis, Aiming for TB-Free Nation by 2025

New Delhi: In a significant move towards eliminating tuberculosis (TB) in India by 2025, five years ahead of the global target, the Union Ministry of Health & Family Welfare has approved the introduction of the BPaLM regimen—a groundbreaking treatment for Multi-Drug-Resistant Tuberculosis (MDR-TB). This innovative regimen, introduced under the National TB Elimination Program (NTEP), offers a shorter and more effective treatment option for the country’s 75,000 drug-resistant TB patients.

The BPaLM regimen combines four drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. Pretomanid, a key component of this combination, has been licensed for use in India by the Central Drugs Standard Control Organization (CDSCO) and is expected to significantly enhance the country’s fight against MDR-TB. The regimen provides a highly effective and safe alternative to traditional treatments, reducing the treatment duration from up to 20 months to just six months, with fewer side effects and a higher success rate.

Health experts have validated the new treatment through a thorough review, and a Health Technology Assessment confirmed that the BPaLM regimen is not only safe but also cost-effective, ensuring better outcomes for patients and healthcare systems.

The Government of India’s decision to introduce the BPaLM regimen aligns with Prime Minister Narendra Modi’s vision to rid the country of TB by 2025. This ambitious target comes well ahead of the global goal set under the Sustainable Development Goals (SDGs). By rolling out this new treatment, the government aims to accelerate progress toward ending TB nationwide.

A country-wide, time-bound rollout plan for the BPaLM regimen is being developed by the Central TB Division in consultation with state and union territories (UTs). The plan includes extensive training and capacity building for healthcare professionals to ensure the safe and effective administration of the new treatment across the country.

Bureau The News Hashtag

Recent Posts

Odisha Partners with J-PAL South Asia to Bring Research Evidence into Policymaking

Bhubaneswar: From education and agriculture to gender and governance, the Odisha Government plans to strengthen…

3 days ago

ECoR Extends Sambalpur–Santragachi Special Trains, Adds Coaches to Four Delhi Trains

Bhubaneswar: In view of the increased passenger rush during the festive season, the East Coast…

4 days ago

Odisha Plans 290 More Public EV Charging Stations in 13 Cities, Highways

Bhubaneswar: Odisha has proposed setting up 290 additional public electric vehicle (EV) charging stations across…

4 days ago

Heritage Enthusiast and Former NABM Director Dipak Samantrai Dies at 69

Cuttack: Dipak Samantrai, former Director of the National Academy of Broadcasting and Multimedia (NABM), noted…

4 days ago

Odisha Reviews Development of 588-km National Waterway-5 to Boost Industrial Connectivity

Bhubaneswar: The Odisha Government has assured full support for the development of National Waterway-5 (NW-5),…

4 days ago

Odisha Deploys Four IAS Officers to Oversee Relief and Restoration in Cyclone-Hit Districts

Bhubaneswar: The Odisha Government has deployed four IAS officers as Additional Special Relief Commissioners (Additional…

4 days ago